Healthcare AI Acquisition Corp.
HAIAF
Other OTC10.86
USD
+10.86
- -
CIK
0001848861
ISIN
KYG4373K1094
CUSIP
G4373K109
Return %
Stock
S&P500
1Y
-7.97
18.21
3Y
4.02
64.38
5Y
10.37
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jiande Chen
- Full Time Employees
- 2
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 8 The Green Dover DE United States of America 19810
- IPO Date
- Feb 1, 2022
- CIK
- 0001848861
- Similar Companies
- Business
- Healthcare AI Acquisition Corp. operates as a special purpose acquisition company focused on identifying and executing a business combination within the healthcare AI sector. The company aims to merge with or acquire a target that advances artificial intelligence applications in healthcare, including e-clinical solutions, healthcare information technology, and outsourced pharmaceutical services, to create a platform positioned for growth in medical data analytics, digital health, and AI-enabled medical workflows. Headquartered in the Cayman Islands, with initial formation in 2021, HAIAF pursues strategic partnerships and potential mergers in collaboration with Leading Partners Limited to accelerate deal execution and value creation for shareholders. Main products and services - SPAC vehicle for strategic mergers and acquisitions in healthcare AI - Targeted acquisition pipeline management for healthcare AI companies - Share exchange and reorganizational services related to merger integrations - Advisory and governance services associated with merger deliberations - Potential post-merger business integration services for AI-enabled healthcare platforms - Access to capital markets activity, including redemptions and sponsor-led financing mechanisms - Ongoing investor relations and regulatory disclosures related to the SPAC lifecycle - Strategic partnership facilitation with healthcare AI developers and service providers Latest major company changes - Strategic alliance with Leading Partners Limited to identify and pursue healthcare AI merger targets, signaling a sharpened focus on a preferred partner ecosystem - Extension of merger timeline and postponement of annual general meeting to advance negotiations and finalize a business combination with a healthcare AI entity - Ongoing efforts to solidify a viable target in the healthcare AI space, with management updates reflecting milestones toward a potential acquisition or business combination - No revenue generation or operating cash flow; continued emphasis on capital preservation and target identification in a volatile macro environment - Founding and continuation of corporate governance processes typical for SPACs, including public disclosures and regulatory filings as the search for a suitable target continues Additional context - Industry: Financial services; special purpose acquisition company focusing on healthcare AI - Business segments: Shell-company merger vehicle; target screening and deal execution; post-merger integration planning - Geographic operations: Headquarters in the Cayman Islands; target opportunities primarily in global healthcare AI markets - Founding year and headquarters: 2021; George Town, Cayman Islands - Subsidiaries/parent: No significant operating subsidiaries; shell structure under sponsor governance with potential future merger partner - Target markets and customers: Investors and prospective target companies in healthcare AI, including e-clinical platforms, health IT vendors, and outsourced pharmaceutical service providers - Corporate developments: Ongoing strategy to extend the timeline for completing a business combination; collaborations with potential strategic partners to enhance deal execution and value realization
Leading Group, an Insurance Channel Specialist in China, to be Publicly Listed through a Merger with Healthcare AI Acquisition Corp. (NASDAQ: HAIA)
Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter
Healthcare AI Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination